Full Text View
Tabular View
No Study Results Posted
Related Studies
Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study)
This study is currently recruiting participants.
Study NCT00452829   Information provided by Institute of Child Health
First Received: March 27, 2007   No Changes Posted

March 27, 2007
March 27, 2007
 
 
 
 
No Changes Posted
 
 
 
Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study)
Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study)

The aim of the study is to develop a randomised, double blind clinical trial to compare (i) folic acid plus inositol, with (ii) folic acid plus placebo, for prevention of recurrent neural tube defects.

 
Phase I
Interventional
Randomized, Double-Blind, Placebo Control, Parallel Assignment
Recurrent Neural Tube Defects
  • Drug: Folic Acid and inositol
  • Drug: Folic acid and placebo
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
100
 
 

Inclusion Criteria:

  • Women with a history of one or more isolated neural tube defects (spina bfida, anencephaly or encepalcele) who wish to embark ipon a further pregnancy
Female
18 Years to 40 Years
Yes
Contact: Mrs K Burren 0207 905 2326 ponti@ich.ucl.ac.uk
United Kingdom
 
NCT00452829
 
05ND07
Institute of Child Health
 
Principal Investigator: Andrew Copp, Prof Institute Of Child Health and Great Ormond Street Hospital
Institute of Child Health
March 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP